China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift 
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless 
Alibaba-Backed Moonshot AI Unveils Kimi K2.5 to Challenge China’s AI Rivals 
Anthropic Raises 2026 Revenue Outlook by 20% but Delays Path to Profitability 
ASML’s EUV Monopoly Powers the Global AI Chip Boom 
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges 
Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday 
First Abu Dhabi Bank Reports 22% Jump in Q4 Profit, Beats Market Expectations 
Volkswagen CEO Oliver Blume Faces Crucial Year as Investors Demand Turnaround Results 
Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025 
The Maire - EuroChem Case: Three Lessons for Global Business 
Google Disrupts Major Residential Proxy Network IPIDEA 
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics 
Samsung Electronics Posts Record Q4 2025 Profit as AI Chip Demand Soars 
UK Politicians Call for Full Competition Review of Netflix’s Warner Bros Discovery Deal 
Puma’s Historic Rivalry With Adidas Enters a New Era as Anta Deal Signals Turnaround Push 
NEW YORK, May 22, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Amyris, Inc. ("Amyris") (NASDAQ:AMRS) securities between March 2, 2017 and April 17, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra-sa/amyris-inc?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) in the first quarter of 2017, Amyris made a decision to take an equity stake in one of Blue California’s affiliates that focused on the sweetener market in lieu of cash payment under the license agreement; (2) consequently, due to Amyris’ decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
If you suffered a loss in Amyris you have until June 19, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sa/amyris-inc?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
